Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Medtronic Clinical Trial Evaluating The Newest Radiofrequency Ablation Tools For Atrial Fibrillation Completes Enrollment
Medtronic, Inc. (NYSE:MDT) announced completion of enrollment in the TTOP-AF (Tailored Treatment of Permanent Atrial Fibrillation) clinical trial. The study is evaluating the use of the latest radiofrequency (RF) ablation technology, the Medtronic Ablation Frontiers Cardiac Ablation System, for the treatment of continuous atrial fibrillation (AF). A leading advancement from currently available RF ablation tools, the system is comprised of a RF generator (or energy ) and three anatomically shaped mapping and ablation catheters that target three areas of the heart for AF treatment. The system is approved for use in Europe and is under investigational use in the United States.
generic viagra online
Latest Replikins Data Predicts Continued High Level Of H1N1 (Swine Flu) Infectivity And Lethality
Biotech firm Replikins Ltd. released its analysis of the June and July genomic data that predicts the rates of infectivity and lethality of the H1N1 (Swine Flu) virus. The quantitative analysis shows continued elevated levels in the Replikin Counts* of both Infectivity and Lethality genes, which indicate that the end of the current outbreak is not yet in sight.
News of the day
What Is Cystitis? What Causes Cystitis?
Cystitis refers to inflammation of the lining of the bladder. It usually occurs when the normally sterile urethra and bladder (lower urinary tract) are infected by bacteria and become irritated and inflamed. Cystitis is fairly common and can affect both men and women and people of all ages. However, it is more common in women.
Health Insurance

PM&R Accepted For Abstracting And Indexing In MEDLINE

Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that PM&R - The journal of injury, function and rehabilitation, the official scientific journal of the American Academy of Physical Medicine and Rehabilitation (AAPM&R), has been accepted for coverage by MEDLINE, just six months after its launch in January 2009. Under the guidance of Editor-in-Chief Stuart M. Weinstein, MD, Clinical Professor of Rehabilitation Medicine at the University of Washington, Seattle, and an internationally renowned Editorial Board, this monthly, peer-reviewed, scholarly publication has a clinical focus, presenting an array of topics pertinent to physiatrists (rehabilitation medicine physicians), to those in other related medical disciplines, as well as to a wider international readership. "It is particularly gratifying that a fledgling journal such as PM&R has already been recognized for its contribution to the advancement of physical medicine and rehabilitation," commented Dr. Weinstein. "Working in close partnership with the AAPM&R it is our goal to raise the scientific bar and build bridges between practitioners and researchers across this multidisciplinary field. I am thankful to the entire editorial and publishing team who have committed to the success of this journal." MEDLINE abstracting and indexing of PM&R will start as soon as possible and will be retroactive to Volume 1/Issue 1. MEDLINE is the U.S. National Library of Medicine"s premier bibliographic database containing over 16 million references to journal articles in life sciences with a concentration on biomedicine. PM&R was evaluated and selected for inclusion based on a stringent review process conducted by the Literature Selection Technical Review Committee, an NIH-chartered advisory committee of external experts. MEDLINE records of PM&R articles will also be accessible via PubMed®. "Rapid acceptance by MEDLINE clearly acknowledges the high-quality, significant work already published in PM&R and the continuing efforts of the highly-respected editors, reviewers and the Academy. We at Elsevier would like to thank them all for their contribution to this excellent achievement," stated Elsevier"s Herb Niemirow, Publisher of PM&R. Popularly known as the "Purple Journal," PM&R publishes articles that are contemporary and important to both clinical research and practice. The various sections of the journal highlight original research including clinical trials and observational studies, clinically relevant translational science, comprehensive and focused review articles, case presentations, point/counterpoint discussions and commentary, ethical-legal topics, practice management updates, topical study guides, editorial and opinion pieces, and clinical pearls. Continuing Medical Education opportunities for AMA PRA Category 1 Credit are also offered. PM&R coverage includes acute and chronic musculoskeletal disorders and pain, neurologic conditions involving the central and peripheral nervous systems, rehabilitation of impairments associated with disabilities in adults and children, and neurophysiology and electrodiagnosis. Herb Niemirow Elsevier Health Sciences


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009